iGMDRD96


Canonical SMILES: C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)SCC(C(=O)O)N

InChI: InChI=1S/C22H21NO2S/c23-20(21(24)25)16-26-22(17-10-4-1-5-11-17,18-12-6-2-7-13-18)19-14-8-3-9-15-19/h1-15,20H,16,23H2,(H,24,25)/t20-/m0/s1

InChI Key: DLMYFMLKORXJPO-FQEVSTJZSA-N

Loading, please wait...
Standard Name
Pubchem CID
Drug Status
Drug Type
Standard NameS-Trityl-L-cysteine
Pubchem CID76044
Drug StatusAlone
Drug TypeSmall Molecule

Drug Targets:

KIF11

Drug Pathways:

Mitosis

Drug-model tissue-cancer distribution: Bubble Plot

BLOOtissue: BLOO cancer: BLOOD model num: 0BLOODtissue: BLOOD cancer: undefined model num: 3undefinetissue: undefine cancer: undefined model num: 0undefinedtissue: undefined cancer: PANCAN model num: 10BREAStissue: BREAS cancer: BREAST model num: 0BREASTtissue: BREAST cancer: Breast Carcinoma model num: 1

Drug-gene pathway enrichments

Drug-gene GO enrichments

Drug-Gene: Aster Plot


Loading, please wait...
Gene ID
Gene Name
Model Num.
6714 SRC 1
4292 MLH1 1
162979 ZNF296 1
1938 EEF2 1
Showing 1 to 4 of 7 rows

Gene in drug-gene network: Network Plot

Models in S-Trityl-L-cysteine

Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
EXP(CKIT) protein MCLP BLOOD undefined S.Trityl.L.cysteine sensitivity in vitro
EXP(P38MAPK) protein MCLP BLOOD undefined S.Trityl.L.cysteine sensitivity in vitro
EXP(TAZ_pS79) protein MCLP BLOOD undefined S.Trityl.L.cysteine resistance in vitro
EXP(CRAF) protein MCLP undefined PANCAN S.Trityl.L.cysteine resistance in vitro
EXP(EEF2) protein MCLP undefined PANCAN S.Trityl.L.cysteine resistance in vitro
EXP(HER3) protein MCLP undefined PANCAN S.Trityl.L.cysteine sensitivity in vitro
EXP(SRC) protein MCLP undefined PANCAN S.Trityl.L.cysteine sensitivity in vitro
EXP(TWIST) protein MCLP undefined PANCAN S.Trityl.L.cysteine sensitivity in vitro
EXP(TAZ_pS79) protein MCLP undefined PANCAN S.Trityl.L.cysteine resistance in vitro
EXP(ZNF342) protein MCLP undefined PANCAN S.Trityl.L.cysteine sensitivity in vitro
Showing 1 to 10 of 14 rows rows per page

​​​​